CLYM vs IP · $85.8M cap vs P/E 43, rev $11.97B
Climb Bio Inc (CLYM) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
CLYM does not have a complete income-statement cache yet.
Latest reported IP revenue for 2026-06-30 was $11.97B. Net income was $48.0M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
CLYM currently screens at market cap $85.8M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the CLYM and IP stock pages for the full models.
Not investment advice.